Hyundai Motor Company

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Hyundai Motor Co., Ltd. engages in the manufacture and distribution of motor vehicles and parts. It operates through the following segments: Vehicle, Finance, and Others. The Vehicle segment offers motor vehicles. The Finance segment provides financing, leasing and credit cards. The Others segment includes the manufacture of railways. The company was founded on December 29, 1967 and is headquartered in Seoul, South Korea.

Shares of HD Hyundai Marine Solution, the ship repair unit of South Korean billionaire Chung Mong-joon's shipbuilding giant HD Hyundai Heavy Industries, jumped 97% in their trading debut on Wednesday, boosting its market capitalization to 7 trillion won ($5.1 billion).

KKR-Backed Hyundai Ship Repair Company Jumps 97% In Stock Market Debut

HD Hyundai Marine Solution's shares surged in their trading debut after raising more than $540 million in South Korea's biggest initial public offering in more than two years.

HD Hyundai Marine Solution Makes Strong Debut in South Korea

FOUNTAIN VALLEY, Calif. , May 7, 2024 /PRNewswire/ -- The 2024 Hyundai Palisade is the winner of Cars.com's Three-row SUV challenge.

Hyundai 2024 Palisade Wins Three-row SUV Challenge by Cars.com

Hyundai Motor celebrates the official launch of the NorCAL ZERO Project to bring zero-emission freight transportation to the San Francisco Bay Area and California's Central Valley Hyundai Motor teams up with public and private partners to deploy 30 Class 8 XCIENT Fuel Cell, hydrogen-powered trucks to haul freight containers and vehicles NorCAL ZERO Project aims to reduce carbon emissions by over 24,000 metric tons Hyundai Motor sees hydrogen as the clean energy solution for commercial vehicles, leading the way to expand on Hyundai's efforts for port decarbonization in the U.S. OAKLAND, Calif. and SEOUL, South Korea , May 2, 2024 /PRNewswire/ -- Hyundai Motor Company (Hyundai Motor), today celebrated the official launch of NorCAL ZERO Project – a major initiative that is utilizing the company's hydrogen fuel cell technology to bring zero-emission freight transportation to the San Francisco Bay Area and California's Central Valley.

Hyundai Motor Spearheads U.S. Zero-Emission Freight Transportation with NorCAL ZERO Project Launch

Hyundai has agreed to spend nearly $1 billion on Motional, an investment that will give the automaker a majority stake while providing the self-driving startup with the necessary capital to keep operating. The Korean automaker invested $475 million directly into Motional as part of a broader deal that includes buying out joint venture partner Aptiv.

Hyundai is spending close to $1 billion to keep self-driving startup Motional alive

2024 IONIQ 5 upgraded to TOP SAFETY PICK+ 2024 Santa Fe and Sonata each receive TOP SAFETY PICK Parent Company Hyundai Motor Group also leads industry with 18 IIHS TSP/TSP+ awards FOUNTAIN VALLEY, Calif. , May 2, 2024 /PRNewswire/ -- Hyundai leads the industry with nine TOP SAFETY PICK recognitions by the Insurance Institute of Highway Safety (IIHS).

Hyundai Leads Industry with Nine IIHS 2024 TOP SAFETY PICK Recognitions

Aptiv Holdings Ltd

Auto parts supplier Aptiv Plc on Thursday cut its annual sales forecast and said it would reduce equity interest in its self-driving joint venture, Motional, with Hyundai Motor.

Aptiv to lower equity interest in joint venture with Hyundai, cuts FY sales view

Electric vehicle sales increase 31% Best retail month ever for IONIQ 5; up 59% Record April total and retail sales for IONIQ 6, Tucson HEV, Santa Fe HEV and Palisade FOUNTAIN VALLEY, Calif. , May 1, 2024 /PRNewswire/ -- Hyundai Motor America reported total April sales of 68,603 units, a 3% decrease compared with April 2023.

Hyundai Motor America Reports April 2024 Sales

Hyundai Motor Group plans to launch its first hybrid cars in India as early as 2026, three sources said, as the South Korean auto group looks beyond electric vehicles to boost its presence in a key auto market.

Hyundai Motor Group plans hybrid car launch in India, sources say

Three Hyundai Motorsport N-entered Elantra N TCR cars will contest this year's Nürburgring 24 Hours as part of the team's largest effort yet for the famous endurance race The crews for the cars represent three continents and some of the most successful Hyundai Motorsport Customer Racing drivers from TCR series The manufacturer-supported Hyundai line-up for the race will be completed by a Hyundai Driving Experience-entered i30N Fastback in the VT2 Front-Wheel-Drive class. ALZENAU, Germany , April 29, 2024 /PRNewswire/ -- Hyundai will bring its largest team yet to the Nürburgring Nordschleife to contest this year's Nürburgring 24 Hours (May 30-June 2).

Hyundai Motorsport announces three-car team for Nürburgring 24 Hours TCR class

Hyundai partners with Memorial Health Dwaine and Cynthia Willett Children's Hospital of Savannah and Safe Kids Savannah on the Child Passenger Safety Program Hyundai partners with Georgia Southern University to provide STEM scholarships for undergraduate students Hyundai partners with Coastal Bryan Tree Foundation to support reforestation within the Coastal Bryan County region SAVANNAH, Ga. , April 29, 2024 /PRNewswire/ -- Hyundai recently contributed to local Savannah nonprofit organizations to support safety, education, and reforestation in the community.

Hyundai Invests in Safety, Education, and Reforestation in Savannah

Baidu

Hyundai Motor and Kia Corp on Sunday said the companies have signed a memorandum of understanding (MOU) with Baidu Inc to develop technologies for connected cars.

Hyundai Motor, Kia Corp sign agreement with China's Baidu on connected car technology

BEIJING , April 27, 2024 /PRNewswire/ -- On April 25, 2024, CATL (SZ:300750) and Beijing Hyundai signed a strategic partnership agreement at Auto China 2024 to cooperate on Beijing Hyundai's EV projects and to power future Beijing Hyundai electric models with CATL batteries. As a joint venture with a deep presence in China for 21 years, Beijing Hyundai has sold over 12 million vehicles in China, proving reliable vehicle manufacturing capabilities.

CATL and Beijing Hyundai sign strategic agreement on EV batteries

"Aiming to offer a Dengue antiviral treatment course in $100 price range" Hyundai Bioscience decides to conduct dengue clinical trials in Brazil, which has the largest number of Dengue patients and offers a fast-track approval SEOUL, South Korea , April 25, 2024 /PRNewswire/ -- Hyundai Bioscience announced on April 25 th that, after multiple consultations with global clinical research organizations (CRO), it has decided to conduct clinical trials for its 'niclosamide-based Dengue antiviral' in Brazil, which has the highest number of dengue cases and deaths in the world. Hyundai Bioscience outlined two main reasons for choosing Brazil as its Dengue clinical trial regions: Firstly, Brazil has been the most affected country by the Dengue virus.

Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil

The only solution for intractable cancer caused by mutations in the p53 gene Planning clinical trials targeting cancer patients with no available treatment due to p53 gene mutations SEOUL, South Korea , April 25, 2024 /PRNewswire/ -- Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost all cancer types and cause intractable cancers such cases found in ovarian cancer, uterine cancer, esophageal cancer, etc.

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

South Korea's biggest automaker said net profit for the quarter ended March fell 1.3% and warned of intense competition and rising marketing costs.

Hyundai Motor's Earnings Fell on Sluggish Car Demand

South Korea's Hyundai Motor Co reported on Thursday a drop of 2.4% in first-quarter profit, beating analysts forecasts, helped by solid sales of high-margin cars, while a cheaper domestic currency boosted repatriated earnings.

Hyundai Motor's Q1 profit drops 2.4%, beats forecasts

Hyundai Motor Group to establish mid- to long-term strategies to solidify its position as a leading mobility provider in India

Hyundai Motor Group Executive Chair Euisun Chung Visits India to Underline Mid- to Long-term Mobility Strategic Commitments

PHILADELPHIA, PA / ACCESSWIRE / April 24, 2024 / Philly Shipyard, Inc. ("Philly Shipyard"), the sole operating subsidiary of Philly Shipyard ASA (Oslo: PHLY), and HD Hyundai Heavy Industries Co., Ltd. ("HHI"), a subsidiary of HD Hyundai Group, signed a memorandum of understanding (MOU) to explore a potential business relationship relating to future U.S. government shipbuilding projects as well as maintenance, repair and overhaul (MRO) projects.

Philly Shipyard and HD Hyundai Heavy Industries Sign Memorandum of Understanding

U.S. News & World Report honors Hyundai with the most hybrid and electric awards of any brand IONIQ 5 named Best Electric SUV, IONIQ 6 named Best Electric Sedan, Tucson Hybrid named Best Hybrid SUV FOUNTAIN VALLEY, Calif. , April 24, 2024 /PRNewswire/ -- Hyundai vehicles have been recognized with a trio of 2024 Best Cars Hybrid and Electric Car Awards by U.S. News & World Report, the most awards of any brand.

Hyundai Dominates U.S. News & World Report's Best Hybrid and Electric Cars Awards

The IPO by HD Hyundai Marine Solution would mark the largest share sale in South Korea in two years.

HD Hyundai's Ship Maintenance Firm to Raise $540 Million in South Korea IPO

Hyundai Hope supports car seat safety and Injury Prevention Program Families attended car seat safety check event at CHM Specialty Center DETROIT , April 23, 2024 /PRNewswire/ -- Hyundai Hope, the corporate social responsibility initiative of Hyundai Motor America, announced its partnership with the Children's Hospital of Michigan through the Children's Foundation in support of the hospital's Injury Prevention Program, specifically child passenger safety initiatives. This donation will allow the hospital to purchase car seats for its car seat safety program, which helps ensure the safety and well-being of children while on the road.

Hyundai Partners with Children's Hospital of Michigan for Car Seat Safety Program

Clinical trials of Niclosamide-based oral metabolic anticancer drug to commence for patients with difficult-to-treat cancers such as triple-negative breast cancer and pancreatic cancer Niclosamide-based oral anticancer drug project to be carried out by the new subsidiary of Hyundai Bioscience SEOUL, South Korea , April 22, 2024 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ 048410) announced the positive results from its preclinical study on triple-negative breast cancer, investigating combination therapy of 'Niclosamide-based oral anti-cancer drug' jointly developed with CNPharm and Docetaxel, one of widely-used chemical anticancer agents. As a result, the combination therapy was found to be more effective than Docetaxel alone.

Hyundai Bioscience announces its successful result from a preclinical study of a Niclosamide-based oral anticancer drug to treat triple-negative breast cancer

SEOUL, South Korea , April 18, 2024 /PRNewswire/ -- South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection. "The fundamental way to deal with Dengue fever is taking the antiviral drug, which is effective on all four serotypes of the Dengue virus, in the early stage of virus infection," CEO Oh said.

Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization

South Korea's Hyundai said on Friday that it had paused advertising on X, formerly known as Twitter, and is speaking to the Elon Musk-owned social media platform directly about brand safety issues.

News for Hyundai Motor Company Stock (HYMTF)